Akèy › Kansè kolon › Illinois › Chicago
Etid klinik pou Kansè kolon nan Chicago, IL
14 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Family Communications After Genetic Testing
Ap rekriteVolontè an sante akeyi
- Advocate Illinois Masonic Medical Center, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
Ap rekriteFaz 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Ap rekriteFaz 3
- University of Illinois Cancer Center, Chicago
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Ap rekrite
- John H Stroger Jr Hospital of Cook County, Chicago
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Ap rekriteFaz 2/3
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- ak 5 plis
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Ap rekriteFaz 1/2
- Northwestern University, Chicago
Shield Post-Approval Study Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- GI Solutions of Illinois, Chicago
- GI Solutions of Illinois, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Ap rekriteFaz 2
- City of Hope at Illinois Chicago Downtown, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- University of Chicago, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Ap rekriteFaz 3
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Chicago
Etid Kansè kolon nan lòt vil
- Boston, MA22 etid
- New York City, NY22 etid
- Houston, TX20 etid
- Nashville, TN16 etid
- Los Angeles, CA16 etid
- Arlington, VA15 etid
- St. Louis, MO15 etid
- Baldwin Park, CA14 etid
- San Antonio, TX14 etid
- Tampa, FL13 etid
- Baltimore, MD13 etid
- Washington, DC12 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.